tirzepatide patient assistance program What is Lilly Cares Tirzepatide Injections Near Me in

Reviewed for scientific accuracy by: Dr

7 In a 52-week study of 1,995 patients (modified intention-to-treat population) with type 2 diabetes taking up to three oral hypoglycemic agents and at an increased risk of cardiovascular events, tirzepatide was superior to insulin glargine at all three doses

Injection site reactions such as redness, itching, or mild swellingoccur in approximately 2-3% of patients and are generally self-limiting

These help lower body weight and improve blood sugar levels

The triple-action mechanism might require different dose adjustments compared to dual agonists

The gastric-slowing effect of tirzepatide typically becomes less pronounced over time with continued treatment at a stable dose